Dear Madam Attorney General James:

Today xNY.io - Bank.org repecfully recommends an independent investigation into NYDFS Superintendent Harris' potential rigging of New York State’s Vyvanse marketplace (B12). 

xNY.io - Bank.org has information from Australia that seemingly confirms our claim.  

See here: 

Marianne Williamson LIVE in Melbourne, Australia | July 2022: https://drive.google.com/file/d/10GI5UDN7PVLcShqj0S_N7E28lpC-vkeC/view?usp=drivesdk

Novo Nordisk's Obesity Drug Study Allegedly Duped Investors

By Dorothy Atkins

Novo Nordisk was hit with a proposed securities class action in New Jersey federal court Friday, accusing the drugmaker of duping investors about its new weight loss drug CagriSema by failing to disclose that obesity patients were taking different dosages in a clinical study, which allegedly skewed results.

 Complaint attached | Read full article » | Save to favorites »

Furthermore, I am concerned that Ms. Harris' likley role in rigging New York State’s Vyvanse marketplace (B12) shares themes with Novo Nordisk that could exasterbate insurance fraud claims at NYAG. 

Kindly confirm if NYAG will open a Vyvanse marketplace rigginging investigation (B12) by February 12, 2025. 

Warm regards,

Gunnar Larson